Skip to Main Content (Press Enter)
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
IT
EN
☰
Competenze & Professionalità
|
Competenze & Professionalità
unibs.it
IT
EN
×
Home
Persone
Strutture
Competenze
Pubblicazioni
Professioni
Corsi
Insegnamenti
Terza Missione
☰
Pubblicazioni
THE LANCET. HAEMATOLOGY
Rivista
Codice:
E233109
ISSN:
2352-3026
Dati Generali
Dati Generali
Pubblicazioni (7)
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study
Articolo
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study
Articolo
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Articolo
Efficacy and safety of extended duration letermovir prophylaxis in recipients of haematopoietic stem-cell transplantation at risk of cytomegalovirus infection: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Articolo
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT
Articolo
Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial
Articolo
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
Articolo
No Results Found
